HIV/AIDS and Infections research hub

A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

This study looks at new treatments for HIV called ‘broadly neutralising antibodies’ (bNAbs). It aims to see if two specific bNAbs can help control HIV without daily medication in people who started treatment shortly after getting HIV.